Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.
Qianqian SongBenjamin A BatesYu Raymond ShaoFang-Chi HsuFeifan LiuVithal MadhiraAmit Kumar MitraTimothy BergquistRamakanth KavuluruXiaochun LiNoha SharafeldinJing SuUmit TopalogluPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Real-world evidence shows that patients with cancer, especially hematologic malignancies, are at higher risk for developing breakthrough infections and severe outcomes. Patients with vaccination were at markedly decreased risk for breakthrough infections. Further work is needed to assess boosters and new SARS-CoV-2 variants.